News Agencies Feed 

HEALTHCARE

2019 Edogawa NICHE Prize Awarded to Dr. Steven Rosenberg for His Pioneering Feat in Tackling Cancer with Immunotherapy
August 15, 2019

The Edogawa NICHE Committee today announced that the 2019-Edogawa NICHE Prize (www.edogawanicheprize.org) has been awarded to Dr. Steven A. Rosenberg, for his pioneering work in developing effective adoptive immunotherapies and genetically modified T cells which has heralded the birth of a new chapter in the fight against cancer. Dr. Rosenberg’s accomplishment has significantly contributed to the development of several immune system-based drugs and clinically effective immunotherapies including the CAR-T cell therapy. Dr. Rosenberg is an epitome of significance of inter-disciplinary interaction in developing clinical solutions, who after his Medical degree at Johns Hopkins University, obtained doctorate in Biophysics. Now leads a strong interdisciplinary team devoted to find novel solutions to......

Continue Reading >

AHF Applauds Appointment of Winnie Byanyima as Head of UNAIDS
August 15, 2019

AHF lauded today a historic decision by the United Nations Secretary-General to appoint Winnie Byanyima as the new Executive Director of the Joint United Nations Programme on HIV/AIDS (UNAIDS). Byanyima, who is a prominent Ugandan diplomat and humanitarian, will be the first woman Executive Director to lead the agency since its launch in 1996.

Byanyima’s appointment comes in the wake"...

Continue Reading >

KSA hosted a successfully haj season
August 14, 2019

MINA — The World Health Organization (WHO) congratulated Saudi Arabia Government and the Ministry of Health for successfully hosting the haj season 1440/2019 without a single public health event or disease outbreak being reported among pilgrims performing the haj.

In addition, WHO expressed its deep appreciation to all the health care heroes and volunteers for their dedication in providing health care services to 2.5 million pilgrims.
...

Continue Reading >

Concept Medical Granted “Breakthrough Device Designation” by FDA for MagicTouch PTA Sirolimus Coated Balloon
August 14, 2019

Concept Medical Inc. (CMI) has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for MagicTouch PTA (Percutaneous Transluminal Angioplasty), its Sirolimus drug coated balloon (DCB) catheter, for the treatment of Peripheral Artery Disease (PAD) in Below-the-Knee (BTK). Concept Medical Inc. is backed by cardiologist, philanthropist and serial entrepreneur Dr. Kiran Patel, a staunch supporter of innovative and disruptive medical devices, providing breakthrough treatments to the people of the world. Under the leadership of drug delivery pioneer Dr. Manish Doshi, the company has initiated an extensive range of worldwide clinical programs to create evidence for its innovative drug delivery devices. Concept Medical Inc has pioneered the Sirolimus drug delivery platform technology (Nanolute Technology) which has a proven commercial history in the coronary applications in more than 30,000 patients worldwide. MagicTouch PTA Sirolimus......

Continue Reading >

Emirates Hospital- Jumeirah, among five hospitals in the region to receive CORE certification
August 14, 2019

Emirates Hospital - Jumeirah was recently awarded the Collaboration of Organised and Recognised Endoscopy units (CORE) certificate by the World Endoscopy Organisation (WEO). Only five hospitals in the entire region received this recognition.

Through this recognition WEO is looking at reaching out to endoscopy units worldwide to improve the quality of practice of endoscopy. The certification"...

Continue Reading >

Study Demonstrates Reduction in Mortality Using Masimo Noninvasive, Continuous Hemoglobin (SpHb®) and Pleth Variability Index (PVi®) Monitoring
August 8, 2019

Masimo (NASDAQ: MASI) announced today that in a study published in the Journal of Clinical Monitoring and Computing, researchers investigated the effects of implementing a hospital-wide fluid and blood administration protocol using two Masimo measurements: noninvasive, continuous hemoglobin (SpHb®) and pleth variability index (PVi®).1 To evaluate the impact of the implementation, they collected data on transfusions and mortality 30 and 90 days after surgery and compared the findings between two 11-month periods in 2013 and 2014. In the study, Dr. Jérôme Cros, Prof. Nathalie Nathan, and colleagues at Hôpital Dupuytren, part of the Centre Hospitalier Universitaire of Limoges, France (CHU Limoges), sought to determine if the use of a goal-directed therapy (GDT) algorithm based......

Continue Reading >

SpeeDx Pty. Ltd. Raises $15 Million From U.S. Investment Partnership
August 6, 2019

SpeeDx Pty. Ltd., the developer of transformative new molecular diagnostic solutions, today announced it had raised up to US $10 million in additional equity investment from US-based Northpond Ventures. This follows an original investment of US $5 million from Northpond Ventures in April 2019.

SpeeDx CEO Colin Denver said, “The funds raised will help expedite our international expansion"...

Continue Reading >

Fakih IVF gives you more of a reason to celebrate this Eid
August 6, 2019

In observation of Eid-al Adha, Fakih IVF Fertility Center, one of the leading Infertility, Gynecology, Obstetrics, Genetics and IVF centers in the GCC Region seeks to reach out to many more couples that are struggling to fulfill their dream of starting a family.

As part of this effort, the fertility center is running an Eid Campaign that promises to extend their services to everyone in"...

Continue Reading >

Two Transmedia Initiatives Aimed at Encouraging Emirati and Arab youth launched by Jawaher Khalifa Al Khalifa Foundation for Youth Empowerment and Art Format Lab
August 6, 2019

Aimed at supporting talented Arab and Emirati youth in the region whilst also honing their scientific and cultural abilities, Sheikha Jawaher bint Khalifa Al Khalifa and Khulud Abu Homos, on Behalf of Jawaher Khalifa Al Khalifa Foundation for Youth Empowerment and Art Format Lab Production, recently signed a strategic partnership agreement, to jointly launch a new media initiative that will host a number of innovative projects primarily focused on encouraging these"...

Continue Reading >

Masimo Announces CE Marking of Neonatal Indication for Noninvasive, Continuous Hemoglobin Monitoring (SpHb®)
August 6, 2019

Masimo (NASDAQ: MASI) announced today the CE marking of SpHb®, noninvasive and continuous hemoglobin monitoring, for neonatal and infant patients (< 3 kg). With this clearance, the benefits of SpHb are available for patients of all ages in CE mark countries. SpHb for neonates and infants is provided on rainbow® sensors, which allow clinicians to simultaneously measure multiple additional noninvasive parameters alongside SpHb, including oxygen saturation (SpO2) and methemoglobin (SpMet®). Because of their small size, neonates and infants have less blood than older patients. In addition, their lack of bone marrow density makes them far less capable than adults of generating new red blood cells for approximately the first eight months of life. Current invasive methodologies for measuring......

Continue Reading >